Applied Therapeutics shareholders may seek corporate reforms, returns, and incentive awards.

Applied Therapeutics (NASDAQ: APLT) has reached a settlement in a securities fraud class action lawsuit. The investigation concerns alleged breaches of fiduciary duties by certain officers and directors. Shareholders who purchased APLT shares prior to January 3, 2024, and still hold shares today, may be eligible for corporate reforms, the return of funds, and a court-approved incentive award.